The Medtronic continuous glucose monitor that I wear has sensors that are FDA approved for 3 days at a time. Given, however, the expense and the pain involved with replacing the sensor, I, like many others, try to wear the … Read more
Medtronic has launched the Enlite Sensor, the newest and most advanced glucose sensor for continuous glucose monitoring (CGM), in more than 35 countries outside of the United States.
The new Enlite Sensor combines greater comfort with improved glucose sensor performance in both overall accuracy and detection of hypoglycemia… Read more
A new study designed to evaluate the effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes has found that continuous glucose monitoring both reduces the amount of time spent by type 1 diabetes patients in hypoglycemia and improves HbA1c levels. The results appear in the April addition of Diabetes Care…. Read more
Deciding to postpone yesterday’s run to this morning, following my hypoglycemic episode was the right thing to do. I woke up at 5:00am this morning and checked my BS – it was 223. High, very high, but I knew this … Read more
I had a very scary night last night. It started out like most nights, nothing unusual. I checked my blood sugar before eating dinner, it was 130, I ate dinner, which included a nice portion of quinoa and some squash, … Read more
The Minimed Paradigm® Revel™ Insulin Pump includes a new feature called predictive alerts that the previous model did not have… Read more
Medtronic, Inc. announced the launch of iPro 2 Professional CGM, a continuous glucose monitoring (CGM) system used by physicians to help improve diabetes management, in 49 countries around the world. This simplified, yet more advanced fourth generation CGM system is valuable for detecting high and low glucose fluctuations that can lead to dangerous health complications. .. Read more
Medtronic, Inc. announced it has received U.S. Food and Drug Administration (FDA) approval for the MiniMed Paradigm® REAL-Time Revel™ System, an integrated diabetes management system which combines insulin pump therapy, continuous glucose monitoring (CGM) and diabetes therapy management software… Read more
No, I’m not talking about diabetes itself. I’m talking about the sensor for my continuous glucometer (CGM). I don’t mean to imply too hostile of a relationship between me and my Abbott Freestyle Navigator — most of the time, I … Read more
According to a JDRF press release, a consortium of academic and industrial partners has announced a collaboration called AP@home that aims to develop an artificial pancreas which would allow automated glucose control for people with insulin treated diabetes.
In the first phase of the AP@home project, currently available AP algorithms will be tested with CGM (continuous glucose monitoring) systems and insulin pumps… Read more